Session Information
-
WCLC 2018
19th World Conference on Lung Cancer
Conference Program for the 19th World Conference on Lung Cancer in Toronto, Canada
Download PDF of the Abstract Book: Click Here.
Presentation Date(s):- Sept 23 - 26, 2018
- Total Presentations: 2391
September 23 Sun
Sep 23 Monday
September 24 Mon
Sep 24 Tuesday
September 25 Tue
Sep 25 Wednesday
September 26 Wed
Sep 26
-
+
P1.01 - Advanced NSCLC (Not CME Accredited Session)
- 16:45 - 18:00
- 9/24/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P1.01-101 - Survival Benefit of Sequential Therapy in ALK Positive Olioprogressive NSCLC Patients After Crizotinib Resistance
16:45 - 18:00 | Presenter: Haiyan Xu | Author(s): Di Ma, Guangjian Yang, Junling Li, Xuezhi Hao, Puyuan Xing, Lu Yang, Yan Wang
- Abstract
Loading... -
+
P1.01-98 - A Phase IIIb Trial of Afatinib in EGFRm+ NSCLC: Analyses of Outcomes in Patients with Brain Metastases or Dose Reductions
16:45 - 18:00 | Presenter: Yi-Long Wu | Author(s): Haiyan Tu, Jifeng Feng, Meiqi Shi, Jun Zhao, Yuyan Wang, Jianhua Chang, Jialei Wang, Ying Cheng, Jing Zhu, Eng-Huat Tan, Kai Li, Yi Ping Zhang, Victor Lee, Cheng-Ta Yang, Wu-Chou Su, David Chi-Leung Lam, BJ Srinivasa, Senthil Rajappa, Ching-Liang Ho, Kwok Chi Lam, Yi Hu, Shailesh Arjun Bondarde, Xiaoqing Liu, Dennis Chin-Lun Huang, Yu Wang, Kaimin Pang, Caicun Zhou
- Abstract
Loading...
-
+
P1.09 - Pathology (Not CME Accredited Session)
- 16:45 - 18:00
- 9/24/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P1.09-13 - Detection of Actionable Mutations in Plasma cfDNA Samples From NSCLC Patients Using a Novel Amplicon-Based Firefly NGS Assay
16:45 - 18:00 | Presenter: Jiatao Lou | Author(s): Lin Wang, Li Weng, Xiao Chen, Min Li, Qiaomei Guo, Wenjun Yu, Qinghe Meng, Hongyan Wang, Tobias Wittkop, Grace Q. Zhao, Malek Fahem, Shengrong Lin
- Abstract
Loading...
-
+
P1.12 - Small Cell Lung Cancer/NET (Not CME Accredited Session)
- 16:45 - 18:00
- 9/24/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P1.12-03 - A Prospective Study of Apatinib in Advanced Small Cell Lung Cancer Patients Failed from Two or More Lines of Chemotherapy
16:45 - 18:00 | Presenter: Yutao Liu | Author(s): Xingsheng Hu, Shengyu Zhou, Junling Li, Peng Liu, Yan Wang, Xueyu Hao, Yuankai Shi, Jun Jiang
- Abstract
Loading...
-
+
P2.01 - Advanced NSCLC (Not CME Accredited Session)
- 16:45 - 18:00
- 9/25/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P2.01-109 - Treatment Duration—A More Reasonable Definition to Evaluate the Efficacy of Crizotinib in ALK Positive Advanced NSCLC
16:45 - 18:00 | Presenter: Guangjian Yang | Author(s): Di Ma, Junling Li, Puyuan Xing, Xuezhi Hao, Haiyan Xu, Yan Wang
- Abstract
Loading...
-
+
P2.13 - Targeted Therapy (Not CME Accredited Session)
- 16:45 - 18:00
- 9/25/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P2.13-04 - Outcomes of ALK-Positive Non-Small-Cell Lung Cancer (NSCLC) Patients Treated with Crizotinib: A Multicenter Cohort Retrospective Study.
16:45 - 18:00 | Presenter: Di Ma | Author(s): Puyuan Xing, Qiang Wang, Xuezhi Hao, Mengzhao Wang, Yan Wang, Li Shan, Tao Xin, Li Liang, Hongge Liang, Yang Du, Zhaohui Zhang, Junling Li
- Abstract
Loading... -
+
P2.13-05 - Real-World Clinical Benefit of Continuing Crizotinib Beyond Progression Disease (CBPD) in Patients with Advanced ALK-Positive NSCLC.
16:45 - 18:00 | Presenter: Di Ma | Author(s): Puyuan Xing, Qiang Wang, Xuezhi Hao, Mengzhao Wang, Yan Wang, Li Shan, Tao Xin, Li Liang, Hongge Liang, Yang Du, Zhaohui Zhang, Junling Li
- Abstract
Loading... -
+
P2.13-30 - High-Dose Icotinib in Advanced Non-Small Cell Lung Cancer with EGFR 21 L858R Mutation: The Randomized, Open-Label INCREASE Study
16:45 - 18:00 | Presenter: Shucai Zhang | Author(s): Xi Li, Li Zhang, Jiang Da, Yan Wang, Aimin Zang, Cuimin Ding, Min Zhao, Wuyun Su, Yan Zhang, Diansheng Zhong, Jin Wu, Guangyu An, Cuiying Zhang, Xingsheng Hu, Gang Cheng, Huaqing Wang, Zhihai Han, Xiaohui He, Junli Liu, Li Liang
- Abstract
Loading... -
+
P2.13-39 - A Phase Ib Trial of the HSP90 Inhibitor AUY922 in Combination with Pemetrexed in Metastatic Non-Squamous, Non-Small Cell Lung Cancer Patients
16:45 - 18:00 | Presenter: Zorawar Noor | Author(s): Jonathan W. Goldman, William E. Lawler, Diane Melancon, Bijoy Telivala, Fadi Braiteh, Brian A. Dicarlo, Kathleen Kennedy, Diego Martinez, Brad Adams, Xiaoyan Wang, Benjamin Jones, Edward B Garon
- Abstract
Loading...
-
+
P2.16 - Treatment of Early Stage/Localized Disease (Not CME Accredited Session)
- 16:45 - 18:00
- 9/25/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P2.16-46 - Clinical Outcomes and Treatment Strategies of Sarcomatoid Carcinoma of the Lung
16:45 - 18:00 | Presenter: Yan Wang
- Abstract
Loading... -
+
P2.16-49 - Which Nomogram is More Reliable to Predict Recurrence of Pathological Stage IA Lung Adenocarcinoma Treated by Surgery?
16:45 - 18:00 | Presenter: Lu Yang | Author(s): Jun Zhao, Jing Zhang, Fei Xu, Haiyan Xu, Guangjian Yang, Jianming Ying, Yan Wang
- Abstract
Loading...
-
+
P3.01 - Advanced NSCLC (Not CME Accredited Session)
- 12:00 - 13:30
- 9/26/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P3.01-103 - Efficacy of Crizotinib in Chinese Non-Small Cell Lung Cancer Patients with Brain Metastasis: A Multicenter Retrospective Study
12:00 - 13:30 | Presenter: Shouzheng Wang | Author(s): Puyuan Xing, Di Ma, Qiang Wang, Xuezhi Hao, Mengzhao Wang, Yan Wang, Li Shan, Tao Xin, Li Liang, Hongge Liang, Yang Du, Zhaohui Zhang, Junling Li
- Abstract
Loading... -
+
P3.01-107 - Correlation Study of Bone Metastasis and Cholesterol Level in Patients with Lung Adenocarcinoma
12:00 - 13:30 | Presenter: Yan Wang
- Abstract
Loading... -
+
P3.01-47 - Clinical Characteristics and Outcome for Patients with Advanced Lung Adenocarcinoma Treated with First-Line Pemetrexed Plus Platinum
12:00 - 13:30 | Presenter: Xue Ji | Author(s): Xingsheng Hu, Yixiang Zhu, Yutao Liu, Lin Lin, Puyuan Xing, Xuezhi Hao, Yan Wang, Junling Li
- Abstract
Loading... -
+
P3.01-65 - First-Line Radical Local Therapy May Provide Additional Survival Gain for Patients with EGFR-Mutant Metastatic NSCLC Receiving TKIs
12:00 - 13:30 | Presenter: Jingbo Wang | Author(s): Xiaotong Lu, Chunyu Wang, Nan Bi, Zongmei Zhou, Yan Wang, Luhua Wang
- Abstract
Loading...
-
+
P3.13 - Targeted Therapy (Not CME Accredited Session)
- 12:00 - 13:30
- 9/26/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P3.13-17 - A Retrospective Study: Central Nervous System Response to Osimertinib in Patients with Advanced NSCLC
12:00 - 13:30 | Presenter: Yuxin Mu | Author(s): Puyuan Xing, Xuezhi Hao, Yan Wang, Junling Li
- Abstract
Loading...